Concerto Biosciences: Funding, Investors & Team (Sep 2026)
Concerto Biosciences reimagines how people interact with microbes. We foresee a world in which each of us regulates the microbial communities within, on, and around us in order to maintain good health. To prepare the way, Concerto created a platform to quickly and thoroughly assess how microorganisms interact with one another. With the use of these measures, Concerto is able to perceive the world for what it really is: a vast underworld network of microbial interactions that affects both the health of our bodies and the health of the planet. The network uncovers novel "ensembles" of microorganisms that collaborate to carry out beneficial human functions. Our initial ensembles repair the skin microbiota, defending against previously incurable conditions like eczema and restore health to millions of people.
Concerto Biosciences has raised $23.0M across 1 funding round on record, the most recent a Series A of $23.0M announced in Nov 2022.
That round is above the $3.0M median round size for Biotechnology Research companies tracked on FundedIQ over the last two years.
Concerto Biosciences Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Concerto Biosciences Funding Rounds
Concerto Biosciences Founders and Leadership Team
Contact details for the Concerto Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Concerto Biosciences Funding Compared to Other Biotechnology Research Startups
Concerto Biosciences' latest round of $23.0M is above the median round in Biotechnology Research. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Concerto Biosciences in Biotechnology Research and Cambridge
Companies Similar to Concerto Biosciences
FibroBiologics is a regenerative medicine firm situated in Houston, Texas that is working on an inventive…
FoamLab specializes in high-performance, bio-based foams made from bacterial nanocellulose and develops a new…
Intrinsic Foundries is pioneering carbon capture and utilization technology that converts industrial waste…
Auxilium Biotechnologies specializes in developing technology for repairing peripheral nerves.
Expedition Medicine's industry-leading chemoproteomics data generating engine learns the rules of molecular…
Avidicure is leading the way in developing a new type of antibody treatment called "AVC-Boosters", which have…
Orange Grove Bio (OGB) is a platform that specializes in investing and developing preclinical drugs, with the…
The Verschuren Centre assists in the advancement of sustainable technologies for cleantech companies and…
A new class of programmable polymer nanoparticles is being developed by Nanite, a next-generation non-viral…
a nonprofit organisation dedicated to reducing greenhouse gas emissions by genetically increasing CO2…
Love Lifesciences is creating a line of injection safety tools that will enhance patient comfort when…
Empatica is a startup that specializes in emotional computing and human data analytics. We create…
Concerto Biosciences Funding FAQs
What does Concerto Biosciences do?
Concerto Biosciences reimagines how people interact with microbes. We foresee a world in which each of us regulates the microbial communities within, on, and around us in order to maintain good health. To prepare the way, Concerto created a platform to quickly and thoroughly assess how microorganisms interact with one another. With the use of these measures, Concerto is able to perceive the world for what it really is: a vast underworld network of microbial interactions that affects both the health of our bodies and the health of the planet. The network uncovers novel "ensembles" of microorganisms that collaborate to carry out beneficial human functions. Our initial ensembles repair the skin microbiota, defending against previously incurable conditions like eczema and restore health to millions of people.
How much funding has Concerto Biosciences raised?
Concerto Biosciences has raised $23.0M across 1 round on record. The most recent is a Series A of $23.0M announced in Nov 2022.
When did Concerto Biosciences last raise funding?
Concerto Biosciences' most recent funding round on record is a Series A of $23.0M, announced in Nov 2022.
Who is the CEO of Concerto Biosciences?
Cheri Ackerman is listed as CEO at Concerto Biosciences.
Where is Concerto Biosciences headquartered?
Concerto Biosciences is based in Cambridge, Massachusetts, United States.
How many employees does Concerto Biosciences have?
Concerto Biosciences is in the 11-50 employee band.
How does Concerto Biosciences' funding compare to other Biotechnology Research startups?
Concerto Biosciences' latest round of $23.0M is above the $3.0M median round size for Biotechnology Research companies on FundedIQ across 24 tracked companies over the last two years.
About FundedIQ's Concerto Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Concerto Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.